Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists

被引:9
作者
Takai, Kentaro [1 ]
Inoue, Yasunao [1 ]
Konishi, Yasuko [1 ]
Suwa, Atsushi [1 ]
Uruno, Yoshiharu [1 ]
Matsuda, Harumi [1 ]
Nakako, Tomokazu [1 ]
Sakai, Mutsuko [1 ]
Nishikawa, Hiroyuki [1 ]
Hashimoto, Gakuji [1 ]
Enomoto, Takeshi [1 ]
Kitamura, Atsushi [1 ]
Uematsu, Yasuaki [1 ]
Kiyoshi, Akihiko [1 ]
Sumiyoshi, Takaaki [1 ]
机构
[1] Dainippon Sumitomo Pharma Co Ltd, Drug Res Div, Suita, Osaka, Japan
关键词
M-1 muscarinic acetylcholine receptor; M-4 muscarinic acetylcholine receptor; Selective agonist; Schizophrenia; Antipsychotic agents; 8-Azatetrahydroquinolone; XANOMELINE; SCHIZOPHRENIA; PHARMACOLOGY; SYMPTOMS; MICE;
D O I
10.1016/j.bmcl.2013.06.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We designed and synthesized N-substituted 8-azatetrahydroquinolone derivatives as selective M-1 and M-4 muscarinic acetylcholine receptors agonists. Optimization of selected derivatives led to the discovery of compound 7 as a highly potent M-1 and M-4 agonist with weak hERG inhibition. Oral administration of compound 7 improved psychosis-like behavior in rats. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4644 / 4647
页数:4
相关论文
共 24 条
[1]  
ANDREASEN NC, 1990, ARCH GEN PSYCHIAT, V47, P615
[2]  
[Anonymous], 2010, J PHARMACOL EXP THER, V334, P171
[3]   Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease [J].
Bodick, NC ;
Offen, WW ;
Levey, AI ;
Cutler, NR ;
Gauthier, SG ;
Satlin, A ;
Shannon, HE ;
Tollefson, GD ;
Rasmussen, K ;
Bymaster, FP ;
Hurley, DJ ;
Potter, WZ ;
Paul, SM .
ARCHIVES OF NEUROLOGY, 1997, 54 (04) :465-473
[4]   Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats [J].
Brady, Ashley E. ;
Jones, Carrie K. ;
Bridges, Thomas M. ;
Kennedy, J. Phillip ;
Thompson, Analisa D. ;
Heiman, Justin U. ;
Breininger, Micah L. ;
Gentry, Patrick R. ;
Yin, Huiyong ;
Jadhav, Satyawan B. ;
Shirey, Jana K. ;
Conn, P. Jeffrey ;
Lindsley, Craig W. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (03) :941-953
[5]  
Bubser Michael, 2012, Handb Exp Pharmacol, P121, DOI 10.1007/978-3-642-23274-9_7
[6]   Extrapyramidal syndromes and new antipsychotic drugs: Findings in patients and non-human primate models [J].
Casey, DE .
BRITISH JOURNAL OF PSYCHIATRY, 1996, 168 :32-39
[7]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[8]   An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine [J].
Dencker, Ditte ;
Weikop, Pia ;
Sorensen, Gunnar ;
Woldbye, David P. D. ;
Wortwein, Gitta ;
Wess, Juergen ;
Fink-Jensen, Anders .
PSYCHOPHARMACOLOGY, 2012, 224 (02) :277-287
[9]  
Eglen RM, 2005, PROGR MED CHEM, V43, P105, DOI 10.1016/S0079-6468(05)43004-0
[10]  
Hirsch S R., 1995, Schizophrenia